In the past decade, the ability to determine complex mechanisms underlying disease has been made easier by a variety of factors, especially the availability of large amounts of data. In fact, with the continuously decreasing costs of obtaining whole exome … Continue reading →

Nephropath™ incorporates DNASTAR pipeline for validating processes against NIST “gold standard.”   The resources provided by the National Institute of Standards and Technology (NIST) Genome in a Bottle (GIAB) consortium promise to greatly improve the reliability of genetic assays. With … Continue reading →